Tuesday, Mar 1, 2022 | 1:00 PM ET

Digital Health Dealmaking by Biopharma and Tech:  An Innovation Match Made in Heaven?

Digital Health Dealmaking by Biopharma and Tech:  An Innovation Match Made in Heaven?

Digital health innovation is guaranteed to play a critical part in the future of biopharma. Innovative technology that can optimize drug discovery, facilitate clinical trials, harness real-world data, improve patient engagement, aid clinical decision-making and enhance personalized care is evolving at breakneck speed. Join our elite industry panel as they explore the most promising partnership strategies between biopharma and tech, rising opportunities and key challenges associated with digital health innovation deals, and how tech and other innovators can position themselves to become a part of biopharma’s digital shift.


Key topics will include:

· Highlights from the headlines in biopharma-tech partnerships

· Key considerations for successful collaborations

· Potential pitfalls and lessons learned in digital health innovation

· Trends, emerging opportunities and areas of anticipated developments



Kellie CombsPartner, FDA Regulatory & Digital Health Co-Chair, Ropes & Gray LLP


Megan BacaPartner, Digital Health Co-Lead, Ropes & Gray LLP

Chris KirbyGeneral Counsel, PathAI

Deb PfennigVP of Business Development, Diagnostics and Enabling Technologies, Janssen

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved